Loading

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support

PeerCurrent

PcPeerCurrent

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Set your cadence Alerts Settings Help

Back to follows

Clinical trial

NCT07361497

1 development in the corpus

NCT07361497

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials1 Reviews Guidelines

Latest

Everything in the corpus, newest first.

SEP 8, 2026 · PHASE 3 TRIAL

A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)

ClinicalTrials.gov

This is a registered Phase 3 trial currently recruiting with no results posted; it describes a planned comparison but carries no outcome data.

PreliminaryNCT07361497 Pumitamig Bristol-Myers Squibb

Reported

Planned enrollment850

PhasePhase 3

Primary outcome measureProgression-free survival (PFS) by BICR per…

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support